Trumps pushes drugs to match down the lowest global values
Trump administrators present the pressure campaign against the remedy of remedy manufacturers in efforts to be able to reduce the amounts of American daily.
President Donald Trump has sent at least 17 drugs, including astrazenecan, Eli Lilly, Johnson & Johnson, and sent them publicly on the Social Media Tacial Turu Nonky on Thursday.
In these characters, Trump gave firms for measures to September 29 to make a series aimed at providing American Innovation prices for Europe and other developed nations. “
These presidential characters are renewed to drug dealers by seeking exactly that certain companies begin to provide other developed countries, “Prices known as the model” the amount of the entire nation.
“No business of Americans who will pay more than other countries with the same drug to the same and generated in the same factory,” said the White House in a statement Monday.
Trump’s latest statements are the latest attempt to carry low prices using the president. Currently, experts begin to question if that unilateral method is the most effective way to reduce drug costs.
“Drug companies can respond to the pressure tactics used by President Trump,” said Juliette Cubabanyki Medicare Policy in Nonprofit KFF, Mail Meaning on the money. “But that reaction may have to reduce the cost of drugs on the board.”
On the other hand, Chris Meecins, a health care policy at Raymond James, told Barron’s On Thursday that, although the Rhetoric, the characters can actually be returned to the lessons made of Trump’s great performance at drug prices, signed in May.
“At first, he said the US would find the best price where any other nation acquires throughout the products,” Meanecins said. “He now fits the categories.”
Trump’s requirements to lower the drug prices
Trump books are directed directly to the tops of the 17 companies including four important demands.
- The drug drivers must provide their full portfolio of existing drugs at a low price donated to other similarities – ankala price – in all the patients performed low-income.
- In all newly developed drugs, companies must receive a contract with the united governance to provide all Americans, even if they have health insurance or independent.
- Trump ordered drug companies to negotiate other countries by communicating to US to “reinstall income from the development of American patients and taxpayers.”
- Drug-operators are directed to cultivate faithful sales models and the Direct-to-business successfully completing the Middleman Prug Management companies.
Trump said he expected that companies were immoral, quickly, and meet the requirements in September September.
“Many suggestions on my management have been ‘solving the’ critical issue that promises a lot,” Trump is written, “to change the requirements of millions of dollars. [the] industry. “
If companies did not adhere, the President threatened “Send all the tools to our Arsenal” to make them take drug prices.
The SPIPMA, a group commercial organization, strongly contradicts the voice of the country’s most popular country, says that “the bad American patients and workers” who cannot afford a new American.
Is Trump actually making drug companies reduce prices?
In the US, higher doctor’s drug prices, especially drugs with names. According to KFF, the lost Ozempics of popular weight, for example, more than 10 Pricer here than in other peers.
The monthly Ozembic list price in the US is $ 936, said Kff. The second most expensive country in analyzing Japan, where $ 169 costs. In Sweden, UK, Australia and France, is less than $ 100.
Outside, Americans spend about $ 100 billion pocket with their instructions last year, high record. Regardless of political relationships, the high price of drugs are a major problem. According to a different KF report, 73% of Americans say there is not enough law on the price of drugs offered.
Enter the renewed turch for push to place the lower drug prices. They followed several methods by biden managers to do the same. Earlier this year, for example, a $ 2,000 drug capabilities in the package began working with Medicare Part Dates as part of the renewal of the Joe Biden Presidency. That law once again allowed Medicare to negotiate drugs with drugs, for the first time, in choosing the most expensive drug.
Those numbers are discussed with it tend to find 2026 in additional drug discussions.
In April, Trump signed a great command you want to expand those discussions while promoting cheap, limited expense of name. Then came his Agastri letters and August’s letters to allow the prices of the most popular “.
Trump told reporters on Sunday that his efforts decrease drug prices.
“You know, we’re a drug price for 1,200, 1,300, 1,400, 1,500%,” says Trump, without providing evidence. “I don’t mean 50%, I mean 14, 1,500%.” (In terms of statistics, it is impossible for prices to dispose of 100%.)
Without both efforts and attempts in Trump, the annual costs called June’s costs, according to the Department of Labor.
As a result of Trump, Cubanski, Nokff, some manufacturers are able to invest in prescription drugs or to introduce new drugs than continue with your insurance or other middlemen. But so far, she adds, these changes do not have broad broad solutions based on the highest price of the US drug
He says that when decreasing prices is not as easy as ordering drug companies to reduce the pressure or the main action, it may have been done.
He says: “Without a tricky law, we may not see a decrease in scheduled price that was moving forward.”
Much from money:
Best hospitals in the US
15 million Americans can lose your health insurance under ‘very much more’
8 of 10 Americans underestimate the amazing cost of long care
